A71 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ascendis Pharma A/S

Watchlist Manager

Watchlist

Price: 206 EUR 0.98% Market Closed

Market Cap: €11.8B

A	Ascendis Pharma A/S F:A71	DK
H	Healthcare Services Group Inc F:HS1	US

Profitability Summary

Ascendis Pharma A/S's profitability score is 48/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

85%

Gross Margin is Increasing

84% > 87%

Negative Operating Margin

-19%

Negative 3Y Average Operating Margin

-195%

Operating Margin is Increasing

-741% > -19%

Negative Net Margin

-32%

Negative 3Y Average Net Margin

-214%

Net Margin is Increasing

-730% > -32%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-182%

Free Cash Flow Margin is Increasing

-672% > 6%

Exceptional ROE

170%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-112%

ROIC is Increasing

-202% > -26%

View All

Hide

Collapse

48 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.